Skip to main content
. Author manuscript; available in PMC: 2016 Feb 23.
Published in final edited form as: J Thorac Cardiovasc Surg. 2014 Jul 24;148(6):2686–2696. doi: 10.1016/j.jtcvs.2014.06.086

TABLE 3.

Comparison of select patient risk factors and processes of care by Society of Thoracic Surgeons predicted risk of mortality (STS PROM) threshold

Variable STS PROM ≤ 1.27% STS PROM > 1.27% P value
Median STS PROM, % 0.7 (0.5, 0.9) 2.4 (1.7, 4.0) <.001
Age, y 59.0 ± 8.7 70.5 ± 9.4 <.001
Gender <.001
 Male 82.7 60.6
 Female 17.3 39.4
Weight, kg 90 (79, 102) 81 (70, 93) <.001
Height, cm 175 (168, 180) 170 (163, 178) <.001
Diabetes 34.9 45.4 <.001
Dialysis 0.1 5.5 <.001
Chronic lung disease <.001
 Mild 7.6 13.1
 Moderate 2.9 8.2
 Severe 0.8 4.8
Immunosuppression 0.8 3.6 <.001
Peripheral vascular disease 7.0 24.2 <.001
Cerebrovascular disease 6.7 22.5 <.001
Cerebrovascular accident 2.3 10.0 <.001
Myocardial infarction 15.4 30.8 <.001
Heart failure 4.6 21.6 <.001
New York Heart Association functional class <.001
 I 8.8 6.6
 II 34.5 21.9
 III 46.3 45.2
 IV 10.4 26.3
Atrial fibrillation 1.8 7.1 <.001
Number of diseased vessels <.001
 One 5.3 2.5
 Two 20.3 14.6
 Three 74.1 82.8
Ejection fraction, % 55 (50, 60) 50 (40, 60) <.001
Status <.001
 Elective 46.5 32.3
 Urgent 53.1 60.0
 Emergent 0.4 7.7
Median surgeon volume 530 (293, 848) 582 (317, 930) <.001
Operative mortality 0.6 3.7 <.001
Beta-blocker (preoperative) 84.0 81.0 <.001
Beta-blocker (discharge) 91.7 83.2 <.001
Antiplatelet (discharge) 96.5 91.6 <.001
Lipid-lowering medication (discharge) 92.1 82.1 <.001

Values are given as median (25th, 75th percentile), mean ± standard deviation, or %. STS PROM, Society of Thoracic Surgeons predicted risk of mortality.